Your English writing platform
Discover LudwigSuggestions(1)
Exact(3)
High-throughput nucleotide sequencing (often referred to as next-generation sequencing; NGS) is increasingly being chosen as a diagnostic tool for cases of expected but unresolved genetic origin.
After a mean duration of 5 (1.0) years, 3 cases of pump dysfunction and 3 cases of (expected) battery end-of-life necessitated replacement of the pump.
In cases of expected moderate-to-severe pain, opioids were added, including oral tramadol or parenteral piritramide (opioid receptor agonist with 0.7 analgesic potency of morphine), applied via patient-controlled analgesia pumps (Fig. 2, Supplementary A and B).
Similar(57)
Statistics: Chi-square, Fisher's exact test (in case of expected values < 5), * p < 0.05 RR relative risk.
Statistics: Chi-square, Fisher's exact test (in case of expected values < 5), two-sample t test, * p < 0.05 GTC generalized tonic-clonic seizure, RR relative risk.
Categorical and continuous variables were analysed using Chi-square or Fisher's exact test (in case of expected values <5) and two-sample t test to identify significant correlations.
Indeed, in the case of observed values, the NEAR OR was 0.357 (0.238–0.535) and in the case of expected values the result was 0.350 (0.235 0.520).
In case of expected cell counts less than five, the Fisher-exact test was used.
In 3 cases (15.0%) of expected increased and rapid bleb scarring, anti-VEGF was given once before starting 5-FU.
The main algorithm for detecting ADRs in SRSs is an approach referred to as disproportionality analysis, which compares the number of observed cases with that of expected cases [ 7].
Standardized prevalence ratios were estimated by dividing the number of observed cases by the number of expected cases in each cluster.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com